Comorbidity, Pain, Utilization, and Psychosocial Outcomes in Older versus Younger Sickle Cell Adults: The PiSCES Project

BioMed Research International

Volumn 2017, Issue , 2017, Pages

  Mcclish, Donna K ^a   Smith, Wally R ^b   Levenson, James L ^b   Aisiku, Imoigele P ^c   Roberts, John D ^d   Roseff, Susan D ^a   Bovbjerg, Viktor E ^e  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD UNIVERSITY   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; COMORBIDITY; CONTROLLED STUDY; COPING BEHAVIOR; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; PAIN INTENSITY; QUALITY OF LIFE; SICKLE CELL; AGE; FEMALE; MALE; MIDDLE AGED; PAIN; PATHOPHYSIOLOGY; PATIENT ATTITUDE; PSYCHOLOGY; SICKLE CELL ANEMIA; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; ANEMIA, SICKLE CELL; COMORBIDITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PATIENT ACCEPTANCE OF HEALTH CARE; YOUNG ADULT;

EID: 85018647198     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2017/4070547     Document Type: Article

References (65)

1. C. Dampier, E. Ely, D. Brodecki, and P. O'Neal, "Home management of pain in sickle cell disease: a daily diary study in children and adolescents, " Journal of PediatricHematology/Oncology, vol. 24, no. 8, pp. 643-647, 2002.
2. C. Dampier, B. Ely, D. Brodecki, and P. O'Neal, "Characteristics of painmanaged at home in children and adolescents with sickle cell disease by using diary self-reports, " Journal of Pain, vol. 3, no. 6, pp. 461-470, 2002.
3. O. S. Platt, B. D. Thorington, D. J. Brambilla et al., "Pain insickle cell disease. Rates and risk factors, "The New England Journal of Medicine, vol. 325, no. 1, pp. 11-16, 1991.
4. J. A. Panepinto, D. C. Brousseau, C. A. Hillery, and J. P. Scott, "Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease, " Pediatric Blood and Cancer, vol. 44, no. 2, pp. 182-186, 2005.
5. W. T. Zempsky, K. A. Loiselle, K. McKay et al., "Retrospective evaluation of pain assessment and treatment for acute vasoocclusive episodes in children with sickle cell disease, " Pediatric Blood and Cancer, vol. 51, no. 2, pp. 265-268, 2008.
6. D. C. Brousseau, P. L. Owens, A. L. Mosso, J. A. Panepinto, and C. A. Steiner, "Acute care utilization and rehospitalizations for sickle cell disease, " The Journal of the American Medical Association, vol. 303, no. 13, pp. 1288-1294, 2010.
7. S. D. Grosse, S. L. Boulet, D. D. Amendah, and S. O. Oyeku, "Administrative data sets and health services research on hemoglobinopathies. A review of the literature, " American Journal of Preventive Medicine, vol. 38, no. 4, pp. S557-S567, 2010.
8. "Consensus conference. Newborn screening for sickle cell disease and other hemoglobinopathies, " The Journal of the American Medical Association, vol. 258, no. 9, pp. 1205-1209, 1987.
9. M. H. Gaston, J. I. Verter, G. Woods et al., "Prophylaxis with oral penicillin in children with sickle cell anemia. Arandomized trial, " New England Journal of Medicine, vol. 314, no. 25, pp. 1593-1599, 1986.
10. M. T. Lee, S. Piomelli, S. Granger et al., "Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results, " Blood, vol. 108, no. 3, pp. 847-852, 2006.
11. W. C. Wang, R. E. Ware, S. T. Miller et al., "Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG), " The Lancet, vol. 377, no. 9778, pp. 1663-1672, 2011.
12. M. H. Steinberg, F. Barton, O. Castro et al., "Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment, " Journal of the American Medical Association, vol. 289, no. 13, pp. 1645-1651, 2003.
13. S. Charache, M. L. Terrin, R. D. Moore et al., "Effect of hydroxyurea on the frequency of painful crises in Sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia, "The New England Journal ofMedicine, vol. 332, no. 20, pp. 1317-1322, 1995.
14. R. E. Ware, B. R. Davis, W. H. Schultz et al., "Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD with Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial, " The Lancet, vol. 387, no. 10019, pp. 661-670, 2016.
15. H. Davis, K. C. Schoendorf, P. J. Gergen, and R. M. Moore Jr., "National trends in the mortality of children with sickle cell disease, 1968 through 1992, " American Journal of Public Health, vol. 87, no. 8, pp. 1317-1322, 1997.
16. R. B. Scott, "Health care priority and sickle cell anemia, " JAMA, vol. 214, no. 4, pp. 731-734, 1970.
17. O. S. Platt, D. J. Brambilla, W. F. Rosse et al., "Mortality in sickle cell disease. Life expectancy and risk factors for early death, " NewEngland Journal ofMedicine, vol. 330, no. 23, pp. 1639-1644, 1994.
18. S. Lanzkron, C. Patrick Carroll, and C. Haywood Jr., "Mortality rates and age at death from sickle cell disease: U. S., 1979-2005, " Public Health Reports, vol. 128, no. 2, pp. 110-116, 2013.
19. D. S. Darbari, P. Kple-Faget, J. Kwagyan, S. Rana, V. R. Gordeuk, and O. Castro, "Circumstances of death in adult sickle cell disease patients, " American Journal of Hematology, vol. 81, no. 11, pp. 858-863, 2006.
20. D. S. Darbari, Z. Wang, M. Kwak et al., "Severe painful vasoocclusive crises and mortality in a contemporary adult sickle cell anemia cohort study, " PLoS ONE, vol. 8, no. 11, Article ID e79923, 2013.
21. B. P. Yawn, G. R. Buchanan, A. N. Afenyi-Annan et al., "Management of sickle cell disease: summary of the 2014 evidencebased report by expert panel members, " JAMA, vol. 312, no. 10, pp. 1033-1048, 2014.
22. P. Adams-Graves and L. Bronte-Jordan, "Recent treatment guidelines for managing adult patients with sickle cell disease: challenges in access to care, social issues, and adherence, " Expert Review of Hematology, vol. 9, no. 6, pp. 541-552, 2016.
23. C. Dampier, P. LeBeau, S. Rhee et al., "Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium, " American Journal of Hematology, vol. 86, no. 2, pp. 203-205, 2011.
24. M. Treadwell, J. Telfair, R. W. Gibson, S. Johnson, and I. Osunkwo, "Transition from pediatric to adult care in sickle cell disease: establishing evidence-based practice and directions for research, " American Journal of Hematology, vol. 86, no. 1, pp. 116-120, 2011.
25. M. Treadwell, S. Johnson, I. Sisler et al., "Self-efficacy and readiness for transition from pediatric to adult care in sickle cell disease, " International Journal of Adolescent Medicine and Health, vol. 28, no. 4, pp. 381-388, 2016.
26. M. Treadwell, S. Johnson, I. Sisler et al., "Development of a sickle cell disease readiness for transition assessment, " International Journal ofAdolescentMedicine andHealth, vol. 28, no. 2, pp. 193-201, 2016.
27. M. R. DeBaun and J. Telfair, "Transition and sickle cell disease, " Pediatrics, vol. 130, no. 5, pp. 926-935, 2012.
28. N. B. Stollon, C. W. Paine, M. S. Lucas et al., "Transitioning adolescents and young adults with sickle cell disease from pediatric to adult health care: provider perspectives, " Journal of Pediatric Hematology/Oncology, vol. 37, no. 8, pp. 577-583, 2015.
29. B. G. Hemker, D. C. Brousseau, K. Yan, R. G. Hoffmann, and J. A. Panepinto, "When children with sickle-cell disease become adults: lack of outpatient care leads to increased use of the emergency department, " American Journal of Hematology, vol. 86, no. 10, pp. 863-865, 2011.
30. A. K. Dickerson, J. Klima, M. M. Rhodes, and S. H. O'Brien, "Young adults with SCD in US children's hospitals: are they different fromadolescents?" Pediatric Blood and Cancer, vol. 58, no. 5, pp. 741-745, 2012.
31. M. A. Blinder, M. S. Duh, M. Sasane, A. Trahey, C. Paley, and F. Vekeman, "Age-related emergency department reliance in patients with sickle cell disease, " Journal of EmergencyMedicine, vol. 49, no. 4, pp. 513-522. e1, 2015.
32. J. R. Frost, R. K. Cherry, S. O. Oyeku et al., "Improving sickle cell transitions of care through health information technology, " American Journal of Preventive Medicine, vol. 51, supplement 1, pp. S17-S23, 2016.
33. A. E. Sobota, E. Umeh, and J. W. Mack, "Young adult perspectives on a successful transition from pediatric to adult care in sickle cell disease, " Journal of Hematology Research, vol. 2, no. 1, pp. 17-24, 2015.
34. L. E. Crosby, C. T. Quinn, and K. A. Kalinyak, "A biopsychosocial model for the management of patients with sicklecell disease transitioning to adult medical care, " Advances in Therapy, vol. 32, no. 4, pp. 293-305, 2015.
35. N. Labore, B. Mawn, J. Dixon, and B. Andemariam, "Exploring transition to self-management within the culture of sickle cell disease, " Journal of Transcultural Nursing, vol. 28, no. 1, pp. 70-78, 2017.
36. S. S. Mulchan, J. M. Valenzuela, L. E. Crosby, and C. Diaz Pow Sang, "Applicability of the SMARTmodel of transition readiness for sickle-cell disease, " Journal of Pediatric Psychology, vol. 41, no. 5, pp. 543-554, 2016.
37. R. Bryant, J. S. Porter, and A. Sobota, "APHON/ASPHOpolicy statement for the transition of patients with sickle cell disease from pediatric to adult health care, " Journal of Pediatric Oncology Nursing, vol. 32, no. 6, pp. 355-359, 2015.
38. K. M. Gil, M. R. Abrams, G. Phillips, and F. J. Keefe, "Sickle cell disease pain: relation of coping strategies to adjustment, " Journal of Consulting and Clinical Psychology, vol. 57, no. 6, pp. 725-731, 1989.
39. F. L. Reese and W. R. Smith, "Psychosocial determinants of health care utilization in sickle cell disease patients, " Annals of Behavioral Medicine, vol. 19, no. 2, pp. 171-178, 1997.
40. W. R. Smith, V. E. Bovbjerg, L. T. Penberthy et al., "Understanding pain and improving management of sickle cell disease: The PiSCES study, " Journal of the National Medical Association, vol. 97, no. 2, pp. 183-193, 2005.
41. W. R. Smith, L. T. Penberthy, V. E. Bovbjerg et al., "Daily assessment of pain in adults with sickle cell disease, " Annals of Internal Medicine, vol. 148, no. 2, pp. 94-101, 2008.
42. A. K. Rosenstiel and F. J. Keefe, "The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment, " Pain, vol. 17, no. 1, pp. 33-44, 1983.
43. K. A. Anie, A. Steptoe, and D. H. Bevan, "Sickle cell disease: pain, coping and quality of life in a study of adults in the UK, " British Journal of Health Psychology, vol. 7, no. 3, pp. 331-344, 2002.
44. J. E. Ware and C. D. Sherbourne, "The MOS 36-item shortform health survey (Sf-36). I. conceptual framework and item selection, " Medical Care, vol. 30, no. 6, pp. 473-483, 1992.
45. A. L. Stewart, R. D. Hays, and J. E. Ware Jr., "The MOS shortform general health survey. Reliability and validity in a patient population, " Medical Care, vol. 26, no. 7, pp. 724-735, 1988.
46. H. Wittink, D. C. Turk, D. B. Carr, A. Sukiennik, and W. Rogers, "Comparison of the redundancy, reliability, and responsiveness to change among SF-36, Oswestry disability index, andmultidimensional pain inventory, " Clinical Journal of Pain, vol. 20, no. 3, pp. 133-142, 2004.
47. D. K. McClish, L. T. Penberthy, V. E. Bovbjerg et al., "Health related quality of life in sickle cell patients: the PiSCES project, " Health and Quality of Life Outcomes, vol. 3, article 50, 2005.
48. S. S. Kazarian and S. B. McCabe, "Dimensions of social support in the MSPSS: factorial structure, reliability, and theoretical implications, " Journal of Community Psychology, vol. 19, no. 2, pp. 150-160, 1991.
49. N. W. Dahlem, G. D. Zimet, and R. R. Walker, "Themultidimensional scale of perceived social support: a confirmation study, " Journal of Clinical Psychology, vol. 47, no. 6, pp. 756-761, 1991.
50. R. L. Spitzer, K. Kroenke, and J. B. W. Williams, "Validation and utility of a self-report version of PRIME-MD: The PHQPrimary Care Study, " Journal of the American Medical Association, vol. 282, no. 18, pp. 1737-1744, 1999.
51. J. L. Levenson, D. K. McClish, B. A. Dahman et al., "Depression and anxiety in adults with sickle cell disease: the PiSCES project, " Psychosomatic Medicine, vol. 70, no. 2, pp. 192-196, 2008.
52. J. L. Levenson, D. K. McClish, B. A. Dahman et al., "Alcohol abuse in sickle cell disease: The Pisces project, " American Journal on Addictions, vol. 16, no. 5, pp. 383-388, 2007.
53. K. Kroenke, R. L. Spitzer, J. B. W. Williams, and B. Löwe, "The Patient Health Questionnaire somatic, anxiety, and depressive symptom scales: a systematic review, " General Hospital Psychiatry, vol. 32, no. 4, pp. 345-359, 2010.
54. A. Sogutlu, J. L. Levenson, D. K. McClish, S. D. Rosef, and W. R. Smith, "Somatic symptom burden in adults with sickle cell disease predicts pain, depression, anxiety, health care utilization, and quality of life: the PiSCES Project, " Psychosomatics, vol. 52, no. 3, pp. 272-279, 2011.
55. S. Charache, M. L. Terrin, R. D. Moore et al., "Design of the multicenter study of hydroxyurea in sickle cell anemia, " Controlled Clinical Trials, vol. 16, no. 6, pp. 432-446, 1995.
56. D. K. McClish, W. R. Smith, B. A. Dahman et al., "Pain site frequency and location in sickle cell disease: The PiSCES project, " Pain, vol. 145, no. 1-2, pp. 246-251, 2009.
57. E. L. Kroner, R. G. Hoffmann, and D. C. Brousseau, "Emergency department reliance: a discriminatory measure of frequent emergency department users, " Pediatrics, vol. 125, no. 1, pp. 133-138, 2010.
58. K. A. Sanders, S. M. Labott, R. Molokie, S. R. Shelby, and J. Desimone, "Pain, coping and health care utilization in younger and older adults with sickle cell disease, " Journal of Health Psychology, vol. 15, no. 1, pp. 131-137, 2010.
59. A. E. Ahmed, A. S. Alaskar, D. K. McClish et al., "SCD in Saudi children, teens and adults: a study in health related quality of life, " Journal of Blood Disorders, vol. 3, no. 1, article 1036, 2016.
60. T. D. H. McKerrell, H. W. Cohen, and H. H. Billett, "The older sickle cell patient, " American Journal of Hematology, vol. 76, no. 2, pp. 101-106, 2004.
61. V. D. A. Citero, J. L. Levenson, D. K. McClish et al., "The role of catastrophizing in sickle cell disease: the PiSCES project, " Pain, vol. 133, no. 1-3, pp. 39-46, 2007.
62. D. K. McClish, J. L. Levenson, L. T. Penberthy et al., "Gender differences in pain and healthcare utilization for adult sickle cell patients: The PiSCES project, " Journal ofWomen's Health, vol. 15, no. 2, pp. 146-154, 2006.
63. C. Dampier, S. Lieff, P. LeBeau et al., "Health-related quality of life in children with sickle cell disease: a report from the comprehensive sickle cell centers clinical trial consortium, " Pediatric Blood and Cancer, vol. 55, no. 3, pp. 485-494, 2010.
64. S. K. Ballas, F. B. Barton, M. A. Waclawiw et al., "Hydroxyurea and sickle cell anemia: effect on quality of life, " Health and Quality of Life Outcomes, vol. 4, article 59, 2006.
65. S. M. Bediako, S. Lanzkron, M. Diener-West, G. Onojobi, M. C. Beach, and C. Haywood, "The measure of sickle cell stigma: initial findings from the Improving Patient Outcomes through Respect and Trust Study, " Journal of Health Psychology, vol. 21, no. 5, pp. 808-820, 2014.